EPCR Ser219Gly: Elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro

Atherosclerosis

Volumn 183, Issue 2, 2005, Pages 283-292

  Ireland, H ^a   Konstantoulas, C J ^a   Cooper, J A ^a   Hawe, E ^a   Humphries, S E ^a   Mather, H ^b   Goodall, A H ^c   Hogwood, J ^c   Juhan Vague, I ^d   Yudkin, J S ^a   Di Minno, G ^e   Margaglione, M ^e   Hamsten, A ^f   Miller, G J ^g   Bauer, K A ^h   Kim, Y T ⁱ   Stearns Kurosawa, D J ⁱ   Kurosawa, S ⁱ  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EALING HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f KAROLINSKA INSTITUTE   (Sweden)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Endothelial protein C receptor; Heart disease; Thrombin

Indexed keywords

ENDOTHELIAL PROTEIN C RECEPTOR; PROTHROMBIN; RECEPTOR PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOVASCULAR RISK; CELL SURFACE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN VARIANT; RACE DIFFERENCE; RISK ASSESSMENT;

ANIMALS; ANTIGENS; ANTIGENS, CD; BLOOD COAGULATION FACTORS; CORONARY DISEASE; CRICETINAE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DNA; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GENE EXPRESSION; GENOTYPE; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTHROMBIN; RECEPTORS, CELL SURFACE; RISK FACTORS; TRANSFECTION;

EID: 27644527760     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.02.028     Document Type: Article

References (35)

1. N. Sattar, C.G. Perry, and J.R. Petrie Type 2 diabetes as an inflammatory disorder Br J Diab Vasc Dis 3 2003 36 41
2. A.D. Pradhan, and P.M. Ridker Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 23 2002 831 834
3. A.J. Krentz Type 2 diabetes and atherosclerotic cardiovascular disease; do they share common antecedents? Br J Diab Vasc Dis/Eur Heart J 23 2002 831 834
4. S.M. Haffner, L. Mykkanen, A. Festa, J.P. Burke, and M.P. Stern Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state 1 Circulation 101 2000 975 980
5. R. Balarajan Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales BMJ 302 1991 560 564
6. R. Balarajan Ethnicity and variations in the nation's health Health Trends 27 1995 114 119
7. C.T. Esmon Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation Crit Care Med 29 2001 S48 S51
8. C.T. Esmon New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins J Exp Med 196 2002 561 564
9. C.T. Esmon Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis Baillieres Best Pract Res Clin Haematol 12 1999 343 359
10. C.T. Esmon Regulation of blood coagulation Biochim Biophys Acta 1477 2000 349 360
11. N.L. Esmon, R.C. Carroll, and C.T. Esmon Thrombomodulin blocks the ability of thrombin to activate platelets J Biol Chem 258 1983 12238 12242
12. C.T. Esmon, N.L. Esmon, and K.W. Harris Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation J Biol Chem 71 1994 7944 7947
13. C. Konstantoulas, E. Hawe, and N. Saut Common variants in the thrombomodulin gene as a risk for myocardial infarction in the north of Europe (HIFMECH Study) Thromb Haemost 91 2004 628 630
14. C.J. Konstantoulas, J. Cooper, and G. Warnock A combination of two common thrombomodulin gene variants influence risk of coronary heart disease: a prospective study Atherosclerosis 177 1 2004 97 104
15. C.T. Esmon, J. Xu, and J.M. Gu Endothelial protein C receptor Thromb Haemost 82 2 1999 251 258
16. F.B. Taylor Jr., G.T. Peer, M.S. Lockhart, G. Ferrell, and C.T. Esmon Endothelial cell protein C receptor plays an important role in protein C activation in vivo Blood 97 2001 1685 1688
17. D.J. Stearns-Kurosawa, S. Kurosawa, J.S. Mollica, J.S. Ferrel, and C.T. Esmon The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex Proc Natl Acad Sci USA 93 1996 10212 10216
18. W. Ruf, A. Dorfleutner, and M. Riewald Specificity of coagulation factor signaling J Thromb Haemost 1 2003 1495 1503
19. D.E. Joyce, L. Gelbert, A. Ciaccia, B. DeHoff, and B.W. Grinnell Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis J Biol Chem 276 2001 11199 11203
20. D.J. Stearns-Kurosawa, K. Swindle, and A. D'Angelo Plasma levels of endothelial protein C receptor respond to anticoagulant treatment Blood 99 2002 530
21. S. Kurosawa, D.J. Stearns-Kurosawa, N. Hidari, and C.T. Esmon Identification of functional endothelial protein C receptor in human plasma J Clin Invest 100 1997 411 418
22. L.M. Regan, D.J. Stearns-Kurosawa, and S. Kurosawa The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors J Biol Chem 271 1996 17499 17503
23. P.C. Liaw, P.F. Neuenschwander, M.D. Smirnov, and C.T. Esmon Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function J Biol Chem 275 2000 5447 5452
24. B. Saposnik, J.L. Reny, and P. Gaussem A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis Blood 103 2004 1311 1318
25. G.J. Miller, K.A. Bauer, S. Barzegar, J.A. Cooper, and R.D. Rosenberg Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease Thromb Haemost 75 1996 767 771
26. J.A. Cooper, G.J. Miller, and K.A. Bauer Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease Circulation 102 2000 2816 2822
27. I.N. Day, S.E. Humphries, S. Richards, D. Norton, and M. Reid High-throughput genotyping using horizontal polyacrylamide gels with wells arranged for microplate array diagonal gel electrophoresis (MADGE) Biotechniques 19 1995 830 835
28. J.S. Yudkin, I. Juhan-Vague, and E. Hawe Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study Metabolism 53 7 July 2004 852 857
29. D.J. Stearns-Kurosawa, C. Burgin, D. Parker, P. Comp, and S. Kurosawa Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations J Thromb Haemost 1 2003 855 856
30. J. Xu, D. Qu, N.L. Esmon, and C.T. Esmon Metalloproteolytic release of endothelial cell protein C receptor J Biol Chem 275 2000 6038 6044
31. J.M. Gu, Y. Katsuura, G.L. Ferrell, P. Grammas, and C.T. Esmon Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo Blood 95 2000 1687 1693
32. P. Medina, S. Navarro, and A. Estelles Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk Thromb Haemost 91 5 May 2004 905 911
33. S. Uitte de Willige, V. Van Marion, and F.R. Rosendaal Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis J Thromb Haemost 2 8 August 2004 1305 1310
34. J. Xu, N.L. Esmon, and C.T. Esmon Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation J Biol Chem 274 1999 6704 6710
35. M. Abdollahi, M. Cushman, and F.R. Rosendaal Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use Thromb Haemost 89 3 March 2003 493 498